JG
LJPC

Jefferies Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Jefferies Group’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,447
Closed -$74K – 3084
2019
Q1 		$74K Buy
+11,447
New +$74.6K ﹤0.01% 2164
2018
Q1 		– Sell
-6,296
Closed -$203K – 3043
2017
Q4 		$203K Buy
+6,296
New +$206K ﹤0.01% 2214

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group's LJPC Position: Q2 2019 in Review

Jefferies Group sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2019, closing a stake of 11,447 shares — an estimated $74K sold.

Jefferies Group first reported a position in LJPC in Q4 2017 and held it in 2 quarters. The position peaked at $203K in Q4 2017. 80 funds tracked by Wall St. Rank hold LJPC as of Q2 2019.

  • Jefferies Group reported no remaining La Jolla Pharmaceutical Company position as of Q2 2019 after selling out during the quarter.
  • Jefferies Group sold 11,447 La Jolla Pharmaceutical Company shares in Q2 2019, an estimated $74K.
  • Jefferies Group first reported a position in La Jolla Pharmaceutical Company in Q4 2017 and held it in 2 quarters.
  • Jefferies Group's La Jolla Pharmaceutical Company position peaked at $203K in Q4 2017.
  • 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2019.

Based on Jefferies Group's 13F filing for Q2 2019, filed 14 Aug 2019.